Missouri, Kansas and Idaho can press forward with their lawsuit to restrict access to the abortion drug mifepristone, a federal judge ruled Thursday, months after the US Supreme Court had rejected an earlier version of the legal challenge.
Efforts to limit access to mifepristone have received a boost from a federal judge who took the bench during Trump's first term.
Three Republican-led states will be allowed to move forward with a lawsuit to restrict access to mifepristone, a Texas federal judge ruled Thursday, months after the Supreme Court rejected an
The Trump-appointed federal judge who unilaterally ordered the FDA to revoke approval of an abortion drug allowed Idaho, Kansas and Missouri to move forward in another lawsuit over mifepristone.
The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public health risk.
The Republican-led states of Idaho, Missouri and Kansas can proceed with a lawsuit seeking to restrict the availability of the abortion pill mifepristone in the United States, a federal judge in Texas ruled on Thursday.
The state's largest health system says physicians are caught between state laws that can limit care, and federal requirements to provide emergency medical treatment.
A Texas judge has allowed three states to move forward with a legal challenge seeking to impose stricter rules on the abortion pill mifepristone, reigniting the battle over medication abortion access in the U.
Idaho, for instance, bans abortion in most circumstances ... They’re challenging FDA rules that have allowed for the drug to be obtained by the mail without an in-person doctor’s visit ...
Some of your go-to snacks contain a highly controversial ingredient that’s now been banned by the federal government.
Small studies going back decades have shown a potential link between artificial food dyes and attention deficit hyperactivity disorder symptoms in kids.
Idaho, Kansas and Missouri can pursue legal action to prohibit the Food and Drug Administration from allowing online prescriptions.